|
36
|
141
|
1jt7A |
Human acidic fibroblast growth factor. 141 amino acid form with amino terminal his tag and leu 44 replaced by phe and leu 73 replaced by val and val 109 replaced by leu (l44f/l73v/v109l) |
|
13
|
59
|
1i0cA |
Eps8 sh3 closed monomer |
|
7
|
59
|
1i07A |
Eps8 sh3 domain intertwined dimer |
|
91
|
246
|
1i37A |
Crystal structure of the rat androgen receptor ligand binding domain complex with dihydrotestosterone |
|
5
|
21
|
1htvA |
Crystal structure of destripeptide (b28-b30) insulin |
|
5
|
27
|
1htvB |
Crystal structure of destripeptide (b28-b30) insulin |
|
41
|
157
|
1ihkA |
Crystal structure of fibroblast growth factor 9 (fgf9) |
|
21
|
106
|
1i1jA |
Structure of melanoma inhibitory activity protein: a member of a new family of secreted proteins |
|
89
|
247
|
1i38A |
Crystal structure of the rat androgen receptor ligand binding domain t877a mutant complex with dihydrotestosterone |
|
3
|
29
|
1hznA |
Nmr solution structure of the third extracellular loop of the cholecystokinin a receptor |
|
39
|
170
|
1gmnA |
Crystal structures of nk1-heparin complexes reveal the basis for nk1 activity and enable engineering of potent agonists of the met receptor |
|
3
|
10
|
1k4wB |
X-ray structure of the orphan nuclear receptor ror beta ligand-binding domain in the active conformation |
|
37
|
170
|
1gp9A |
A new crystal form of the nk1 splice variant of hgf/sf demonstrates extensive hinge movement and suggests that the nk1 dimer originates by domain swapping |
|
6
|
30
|
1g7bB |
1.3 a structure of t3r3 human insulin at 100 k |
|
3
|
30
|
1fubB |
First protein structure determined from x-ray powder diffraction data |
|
1
|
30
|
1fu2B |
First protein structure determined from x-ray powder diffraction data |
|
3
|
21
|
1fu2A |
First protein structure determined from x-ray powder diffraction data |
|
41
|
157
|
1g82A |
Structure of fibroblast growth factor 9 |
|
4
|
21
|
1g7aA |
1.2 a structure of t3r3 human insulin at 100 k |
|
6
|
30
|
1g7aB |
1.2 a structure of t3r3 human insulin at 100 k |
|
9
|
132
|
1fmmS |
Solution structure of nfgf-1 |
|
5
|
21
|
1g7bA |
1.3 a structure of t3r3 human insulin at 100 k |
|
143
|
419
|
1jndA |
Crystal structure of imaginal disc growth factor-2 |
|
3
|
21
|
1fubA |
First protein structure determined from x-ray powder diffraction data |
|
145
|
419
|
1jneA |
Crystal structure of imaginal disc growth factor-2 |
|
20
|
95
|
1fyrA |
Dimer formation through domain swapping in the crystal structure of the grb2-sh2 ac-pyvnv complex |
|
15
|
100
|
1fzvA |
The crystal structure of human placenta growth factor-1 (plgf-1), an angiogenic protein at 2.0a resolution |
|
9
|
28
|
1ev3B |
Structure of the rhombohedral form of the m-cresol/insulin r6 hexamer |
|
5
|
21
|
1ev6A |
Structure of the monoclinic form of the m-cresol/insulin r6 hexamer |
|
8
|
29
|
1evrB |
The structure of the resorcinol/insulin r6 hexamer |
|
5
|
21
|
1evrA |
The structure of the resorcinol/insulin r6 hexamer |
|
9
|
29
|
1ev6B |
Structure of the monoclinic form of the m-cresol/insulin r6 hexamer |
|
5
|
21
|
1ev3A |
Structure of the rhombohedral form of the m-cresol/insulin r6 hexamer |
|
9
|
86
|
1fl7A |
Human follicle stimulating hormone |
|
6
|
107
|
1fl7B |
Human follicle stimulating hormone |
|
15
|
34
|
1et1A |
Crystal structure of human parathyroid hormone 1-34 at 0.9 a resolution |
|
38
|
136
|
1exzA |
Structure of stem cell factor |
|
27
|
115
|
1dvqA |
Crystal structure of human transthyretin |
|
28
|
115
|
1dvyA |
Crystal structure of transthyretin in complex with n-(m-trifluoromethylphenyl) phenoxazine-4,6-dicarboxylic acid |
|
26
|
115
|
1dvxA |
Crystal structure of human transthyretin in complex with diclofenac |
|
25
|
115
|
1dvsA |
Crystal structure of human transthyretin in complex with resveratrol |
|
4
|
21
|
1jcaA |
Non-standard design of unstable insulin analogues with enhanced activity |
|
27
|
115
|
1dvtA |
Crystal structure of human transthyretin in complex with flurbiprofen |
|
26
|
115
|
1dvzA |
Crystal structure of human transthyretin in complex with o-trifluoromethylphenyl anthranilic acid |
|
24
|
115
|
1dvuA |
Crystal structure of human transthyretin in complex with dibenzofuran-4,6-dicarboxylic acid |
|
5
|
30
|
1jcaB |
Non-standard design of unstable insulin analogues with enhanced activity |
|
0
|
8
|
1d6gB |
Molecular complex of cholecystokinin-8 and n-terminus of the cholecystokinin a receptor by nmr spectroscopy |
|
4
|
21
|
1j73A |
Crystal structure of an unstable insulin analog with native activity. |
|
4
|
47
|
1d6gA |
Molecular complex of cholecystokinin-8 and n-terminus of the cholecystokinin a receptor by nmr spectroscopy |
|
6
|
30
|
1j73B |
Crystal structure of an unstable insulin analog with native activity. |
